Search research articles
Contact Us
Filters
Showing results (171-180 of 201) with videos related to
Page
of 21
Sort By:
The American Journal of Cardiology
|
October 16, 1987
Pharmacokinetics of moricizine HCl
R L Woosley, J Morganroth, R N Fogoros, et al.
Circulation
|
April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences
L A Siddoway, K A Thompson, C B McAllister, et al.
The American Journal of Cardiology
|
May 1, 1986
Concentration-dependent pharmacologic properties of sotalol
T Wang, R H Bergstrand, K A Thompson, et al.
The American Journal of Cardiology
|
February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias
H J Duff, D M Roden, A Yacobi, et al.
European Heart Journal
|
April 1, 1995
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study
Z Y Hou, M S Chang, C Y Chen, et al.
The New England Journal of Medicine
|
April 17, 1980
Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics
D M Roden, S B Reele, S B Higgins, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1995
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study
J D Balian, N Sukhova, J W Harris, et al.
Circulation
|
October 1, 1979
Suppression of chronic ventricular arrhythmias with propranolol
R L Woosley, D Kornhauser, R Smith, et al.
The American Journal of Cardiology
|
September 1, 1980
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide
D M Roden, S B Reele, S B Higgins, et al.
Southern Medical Journal
|
September 1, 1981
Recurrent ventricular tachycardia in the absence of overt heart disease: clinical characteristics and response to drug therapy
D M Roden, H J Duff, S B Reele, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 201) with videos related to
Sort By:
Page
of 21
The American Journal of Cardiology
|
October 16, 1987
Pharmacokinetics of moricizine HCl
R L Woosley, J Morganroth, R N Fogoros, et al.
Circulation
|
April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences
L A Siddoway, K A Thompson, C B McAllister, et al.
The American Journal of Cardiology
|
May 1, 1986
Concentration-dependent pharmacologic properties of sotalol
T Wang, R H Bergstrand, K A Thompson, et al.
The American Journal of Cardiology
|
February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias
H J Duff, D M Roden, A Yacobi, et al.
European Heart Journal
|
April 1, 1995
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study
Z Y Hou, M S Chang, C Y Chen, et al.
The New England Journal of Medicine
|
April 17, 1980
Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics
D M Roden, S B Reele, S B Higgins, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1995
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study
J D Balian, N Sukhova, J W Harris, et al.
Circulation
|
October 1, 1979
Suppression of chronic ventricular arrhythmias with propranolol
R L Woosley, D Kornhauser, R Smith, et al.
The American Journal of Cardiology
|
September 1, 1980
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide
D M Roden, S B Reele, S B Higgins, et al.
Southern Medical Journal
|
September 1, 1981
Recurrent ventricular tachycardia in the absence of overt heart disease: clinical characteristics and response to drug therapy
D M Roden, H J Duff, S B Reele, et al.
Page
of 21